Not applicableUnknownNCT03517332What this trial is testingCirculating Tumor DNA Exposure in Peripheral BloodWho this might be right forColorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more Quantgene Inc. 10,000
Early research (Phase 1)Looking for participantsNCT06999187What this trial is testingDR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasWho this might be right forTriple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more Dren Bio 96
Not applicableNot Yet RecruitingNCT06655142What this trial is testingOSCAR II STUDY - The ONCObind CTC Removal StudyWho this might be right forPancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Colorectal Carcinoma (mCRC) ExThera Medical Corporation 120
Not applicableWithdrawnNCT00671463What this trial is testingPancreatic Stent to Prevent Leak After Distal PancreatectomyWho this might be right forPancreatic SurgeryPancreatic Duct StentingPancreatic Cancer+4 more Massachusetts General Hospital
Testing effectiveness (Phase 2)Looking for participantsNCT07285044What this trial is testingThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasWho this might be right forAmyloidosisBasal Cell CarcinomaBiliary Tract Carcinoma+26 more Mayo Clinic 27
Early research (Phase 1)UnknownNCT00090727What this trial is testingChemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forSolid MalignanciesNon-Hodgkin's Lymphoma Novacea 45
Early research (Phase 1)Active Not RecruitingNCT04514497What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerWho this might be right forMetastatic Lung Small Cell CarcinomaMetastatic Malignant Solid NeoplasmMetastatic Neuroendocrine Carcinoma+9 more National Cancer Institute (NCI) 29
Early research (Phase 1)Active Not RecruitingNCT02988960What this trial is testingABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Cancer AbbVie 163
Not applicableUnknownNCT06363123What this trial is testingPlasma Metabolic Biomarkers for Multi-Cancer DiagnosisWho this might be right forLung CancerBreast CancerColorectal Cancer+10 more Beijing Friendship Hospital 2,700
Early research (Phase 1)Study completedNCT00010023What this trial is testingCapecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsWho this might be right forCancer NYU Langone Health
Testing effectiveness (Phase 2)Study completedNCT05546476What this trial is testingStudy of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15Who this might be right forNon-small Cell Lung CancerPancreatic CancerColorectal Cancer+3 more Pfizer 187
Testing effectiveness (Phase 2)Study completedNCT03267316What this trial is testingA First-in-Human Study of CAN04 in Patients With Solid Malignant TumorsWho this might be right forNon Small Cell Lung CancerPancreatic Ductal AdenocarcinomaTriple Negative Breast Cancer+1 more Cantargia AB 167
Testing effectiveness (Phase 2)Study completedNCT00990535What this trial is testingHigh Dose Somatostatin Analogues in Neuroendocrine TumorsWho this might be right forRespiratory Tract NeoplasmsThymic NeoplasmsPancreatic Neoplasms+2 more Federico II University 28
Testing effectiveness (Phase 2)Looking for participantsNCT05985655What this trial is testingStudy to Assess GTAEXS617 in Participants With Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell Carcinoma (HNSCC)Pancreatic AdenocarcinomaNon-small Cell Lung Cancer (NSCLC)+3 more Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 230
Testing effectiveness (Phase 2)Ended earlyNCT03329248What this trial is testingQUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care TherapyWho this might be right forPancreatic Cancer ImmunityBio, Inc. 6
Testing effectiveness (Phase 2)Ended earlyNCT05275478What this trial is testingSafety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsWho this might be right forLocally Advanced Solid Tumor Tango Therapeutics, Inc. 110
Large-scale testing (Phase 3)Looking for participantsNCT04706910What this trial is testing18F-DOPA II - PET Imaging OptimizationWho this might be right forCongenital HyperinsulinismNeuroblastomaParkinson Disease+3 more University of Alberta 800
Not applicableNot Yet RecruitingNCT07619417What this trial is testingEndoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic NeoplasmsWho this might be right forPancreatic NeoplasmPancreatic Neuroendocrine Tumor Ohio State University Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068What this trial is testingStudy of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesWho this might be right forOvarian CancerBreast CancerPancreatic Cancer+10 more AstraZeneca 702
Early research (Phase 1)UnknownNCT06078800What this trial is testingYL-17231 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Shanghai YingLi Pharmaceutical Co. Ltd. 80